These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 31926833)

  • 21. Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type.
    Unizony S; Villarreal M; Miloslavsky EM; Lu N; Merkel PA; Spiera R; Seo P; Langford CA; Hoffman GS; Kallenberg CM; St Clair EW; Ikle D; Tchao NK; Ding L; Brunetta P; Choi HK; Monach PA; Fervenza F; Stone JH; Specks U;
    Ann Rheum Dis; 2016 Jun; 75(6):1166-9. PubMed ID: 26621483
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early predictors of one-year mortality in patients over 65 presenting with ANCA-associated renal vasculitis: a retrospective, multicentre study.
    Titeca-Beauport D; Francois A; Lobbedez T; Guerrot D; Launay D; Vrigneaud L; Daroux M; Lebas C; Bienvenu B; Hachulla E; Diouf M; Choukroun G
    BMC Nephrol; 2018 Nov; 19(1):317. PubMed ID: 30413153
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ANCA associated vasculitis: experience of a tertiary care referral center.
    Chaudhry R; Bilal A; Austin A; Mehta S; Salman L; Foulke L; Feustel P; Zuckerman R; Asif A
    J Bras Nefrol; 2019; 41(1):55-64. PubMed ID: 30095143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence and predictors of severe infections in ANCA-associated vasculitis: a population-based cohort study.
    Rathmann J; Jayne D; Segelmark M; Jönsson G; Mohammad AJ
    Rheumatology (Oxford); 2021 Jun; 60(6):2745-2754. PubMed ID: 33253372
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Muscle biopsy in anti-neutrophil cytoplasmic antibody-associated vasculitis: diagnostic yield depends on anti-neutrophil cytoplasmic antibody type, sex and neutrophil count.
    Lacou M; Leroy M; Le Lan N; Toquet C; Espitia-Thibault A; Graveleau J; Masseau A; Agard C; Volteau C; Mussini JM; Hamidou M; Néel A
    Rheumatology (Oxford); 2021 Feb; 60(2):699-707. PubMed ID: 32789447
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between serologic profile (ANCA type) and clinical features of renal involvement in ANCA-associated vasculitides.
    Bulanov NM; Makarov EA; Shchegoleva EM; Zykova AS; Vinogradova ES; Novikov PI; Lysenko Kozlovskaya LV; Moiseev SV
    Ter Arkh; 2018 Jun; 90(6):15-21. PubMed ID: 30701899
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pulmonary fibrosis in antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis: a series of 49 patients and review of the literature.
    Comarmond C; Crestani B; Tazi A; Hervier B; Adam-Marchand S; Nunes H; Cohen-Aubart F; Wislez M; Cadranel J; Housset B; Lloret-Linares C; Sève P; Pagnoux C; Abad S; Camuset J; Bienvenu B; Duruisseaux M; Hachulla E; Arlet JB; Hamidou M; Mahr A; Resche-Rigon M; Brun AL; Grenier P; Cacoub P; Saadoun D
    Medicine (Baltimore); 2014 Nov; 93(24):340-349. PubMed ID: 25500703
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ANCA positive crescentic glomerulonephritis outcome in a Central East European cohort: a retrospective study.
    Andreiana I; Stancu S; Avram A; Taran L; Mircescu G
    BMC Nephrol; 2015 Jun; 16():90. PubMed ID: 26123651
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Update on diffuse alveolar hemorrhage and pulmonary vasculitis.
    Krause ML; Cartin-Ceba R; Specks U; Peikert T
    Immunol Allergy Clin North Am; 2012 Nov; 32(4):587-600. PubMed ID: 23102067
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A population-based study showing better renal prognosis for proteinase 3 antineutrophil cytoplasmic antibody (ANCA)-associated nephritis versus myeloperoxidase ANCA-associated nephritis.
    Mohammad AJ; Segelmark M
    J Rheumatol; 2014 Jul; 41(7):1366-73. PubMed ID: 24882836
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diffuse alveolar hemorrhage secondary to ANCA-associated vasculitis in a patient with Down syndrome.
    Hori I; Nakaseko H; Kamei M; Nomura T; Iwata N; Ito Y; Saitoh S
    Pediatr Int; 2015 Apr; 57(2):e45-7. PubMed ID: 25868961
    [TBL] [Abstract][Full Text] [Related]  

  • 32. L42. Morbidity in patients with ANCA-associated vasculitis.
    Harper L
    Presse Med; 2013 Apr; 42(4 Pt 2):612-6. PubMed ID: 23465300
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical implication of plasma exchange on life-threatening antineutrophil cytoplasmic antibody-associated vasculitis.
    Park PG; Yoo BW; Song JJ; Park YB; Lee SW
    BMC Pulm Med; 2020 May; 20(1):147. PubMed ID: 32466756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diffuse Alveolar Hemorrhage Secondary to Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Predictors of Respiratory Failure and Clinical Outcomes.
    Cartin-Ceba R; Diaz-Caballero L; Al-Qadi MO; Tryfon S; Fervenza FC; Ytterberg SR; Specks U
    Arthritis Rheumatol; 2016 Jun; 68(6):1467-76. PubMed ID: 26713723
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and histopathological prognostic factors affecting the renal outcomes in childhood ANCA-associated vasculitis.
    Özçelik G; Sönmez HE; Şahin S; Özağarı A; Bayram MT; Çiçek RY; Çakıcı EK; Çomak E; Barut K; Şahin N; Bakkaloğlu S; Gökçe İ; Düzova A; Bilginer Y; Açarı C; Melek E; Kılıç BD; Özdel S; Adroviç A; Kasapçopur Ö; Ünsal E; Alpay H; Orhan D; Topaloğlu R; Düşünsel R; Özen S
    Pediatr Nephrol; 2019 May; 34(5):847-854. PubMed ID: 30607566
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mortality and cardiovascular risk in vasculitis ANCA. Importance of hypertension and renal function. Experience from southern Spain.
    Martin-Gómez MA; Rodríguez Torres A; Espinosa Hernández M; Lopez Mendoza M; Sabio Sánchez JM; Martin Armada M; Martin Suarez I; Callejas Rubio JL; Castilla Castellano MM; Anglada Pintado JC; Barnosi Marín AC; Martinez Esteban MD; Castilla Guerra L; De Ramón Garrido E;
    Hipertens Riesgo Vasc; 2024; 41(1):5-16. PubMed ID: 37517951
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Difference in relapse-rate and clinical phenotype by autoantibody-subtype in Japanese patients with anti-neutrophil cytoplasmic antibody-associated vasculitis.
    Murosaki T; Sato T; Akiyama Y; Nagatani K; Minota S
    Mod Rheumatol; 2017 Jan; 27(1):95-101. PubMed ID: 27320904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rituximab in relapsing and de novo MPO ANCA-associated vasculitis with severe renal involvement: a case series.
    Caroti L; Cirami CL; Di Maria L; Larti A; Carta P; Dervishi E; Farsetti S; Tsalouchos A; Novelli L; Minetti EE
    BMC Nephrol; 2019 May; 20(1):162. PubMed ID: 31088509
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The association of neutrophil-to-lymphocyte ratio with all-cause mortality in Chinese patients with MPO-ANCA associated vasculitis.
    Huang L; Shen C; Zhong Y; Ooi JD; Zhou YO; Chen JB; Wu T; Meng T; Xiao Z; Lin W; Ao X; Tang R; Xiao X; Zhou Q; Xiao P
    Clin Exp Med; 2020 Aug; 20(3):401-408. PubMed ID: 32318926
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Uncommon presentations in ANCA vasculitis: clinical characteristics and outcomes.
    Katikineni VS; Kant S; Gapud EJ; Antiochos B; Manno RL; Phillips M; Seo P; Geetha D
    Clin Rheumatol; 2019 Aug; 38(8):2195-2199. PubMed ID: 31037456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.